Latham & Watkins LLP represented Juno Therapeutics in the transaction. JW Therapeutics completed a US$100 million Series B round financing. This round of financing brings the…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Ambrogio Visconti
…
This content is for Standard 1 Year members only. LoginJoin Now